| 摘要 |
The present invention provides the use of a NK-1 receptor antagonist for the manufacture of a medicament for the treatment or prevention of major depressive disorders, severe anxiety disorders, major depressive disorder when present with anxiety or stress disorders without concomitant therapy with other anti-depressant, anti-anxiety or anti-stress agents, methods of treatment using such a NK-1 receptor antagonist and pharmaceutical compositions comprising the same. |
